Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-001898
Filing Date
2025-01-17
Accepted
2025-01-17 19:05:05
Documents
1
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737158698.html 4  
1 FORM 4 wk-form4_1737158698.xml 4 4642
  Complete submission text file 0001628280-25-001898.txt   6194
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 750 BATTERY STREET, SUITE 330 SAN FRANCISCO CA 94111
Business Address
Taub Rebecca (Reporting) CIK: 0001423898 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 25540018